Smartlab Europe

Press Releases

Catalent’s Investment in Expanding its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland, Increases to $360M

Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced a $230 million expansion project to add three further commercial-scale viral...

MedicalTech Innovation Forum magnifies the importance of innovation and infrastructure in the Indian medical devices industry

The launch edition of MedicalTech Innovation Forum, as Messe Frankfurt India’s first-ever hybrid conference was held at Visakhapatnam in October 2021. Experts from the healthcare industry discussed the need for optimum infrastructure, regulatory framework and innovation in the Indian...

Sustainable pharmaceutical practices: How Bachem is prioritizing their sustainability goals

Looking beyond the financial bottom line and showing consideration for the environment and society is a more astute business decision than usually assumed. It’s not just investors who pay attention to corporate social responsibility, it’s also consumers. More pharmaceutical...

Tjoapack expands into the US with the acquisition of Pharma Packaging Solutions

Tjoapack, a Netherlands-based contract packaging organisation serving the pharmaceutical industry, has acquired US-based Pharma Packaging Solutions, a leading healthcare packaging services business based in Clinton, TN. PPS provides commercial packaging and other, complementary services such as cold chain storage,...

Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. FDA has authorized for emergency use a booster dose of the Moderna COVID-19 vaccine (mRNA-1273) at the 50 µg dose level for people...

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA

Johnson & Johnson announced the U.S. FDA has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single-shot...

A collaboration to enhance the delivery of biotherapeutics and generate transformative therapies for patients

Crystec Ltd. and Biosidus S.A. are delighted to announce their collaboration focused on enhancing the delivery and performance of biotherapeutics. The overarching aim of the non-exclusive partnership is to apply Crystec’s proprietary mSAS® (modified supercritical antisolvent) supercritical fluid particle...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »